Heart to Heart Hospice

Heart to Heart Hospice delivers specialized hospice care services aimed at enhancing the quality of life for patients facing terminal illnesses and offering support to their families. Founded in 2003 and headquartered in Austin, US, Heart to Heart Hospice provides hospice care services focused on patient comfort. The organization has maintained a consistent operational strategy without significant pivots and does not have any known subsidiaries. The founder, Casey Quinn, has not been noted to have founded other companies.

In March 2013, Summit Partners invested in Heart to Heart Hospice, marking their most recent deal. Heart to Heart Hospice specializes in providing compassionate hospice care services for patients facing life-limiting illnesses and their families. Their core offerings emphasize a patient-centered approach that prioritizes comfort and quality of life, featuring interdisciplinary care delivered by healthcare professionals. Services are available in various settings, including private residences, long-term care facilities, and hospitals across Indiana, Michigan, Texas, and Oklahoma.

The organization also collaborates with medical professionals and community education on end-of-life care. Heart to Heart Hospice generates revenue through hospice care services, typically reimbursed by Medicare and various private insurance plans. Revenue is structured around individual patient needs, ensuring personalized care plans. This includes comprehensive services such as medication management and emotional support, navigating the complexities of insurance reimbursement within the hospice industry.

While specific new products have not been stated, the organization is likely focusing on enhancing their service offerings in existing markets. Following the investment from Summit Partners in March 2013, the funding will likely be allocated toward expanding their operational capacity and improving service delivery mechanisms. Heart to Heart Hospice may also be exploring opportunities to enter new geographic regions to serve more patients, although specific targets have not been disclosed.